LCMS Detection and Characterization of In Vitro Metabolites of Isotonitazene, a Targeted Strategy for Novel Psychoactive Substance Control in Camel Racing
Open accessAbstract
RATIONALE: The use of benzimidazole-class novel psychoactive substances has significantly increased worldwide raising concerns about potential misuse and doping in animal sports such as camel racing. Understanding the metabolism of these substances is critical for developing reliable detection methods to ensure fair competition and animal welfare. METHODS: In vitro studies were conducted using homogenized camel liver samples to replicate metabolic processes. Metabolites were extracted and analyzed with a Thermo Fisher Orbitrap Exploris LCMS system. The acquired data were processed using the Compound Discoverer software for accurate detection and characterization of the metabolites. RESULTS: Through in vitro investigation, we have successfully identified nine metabolites in camels, which provide valuable insights into their metabolic pathways. The primary pathways for the formation of phase I metabolites were dealkylation and hydroxylation; the characterized metabolites can be used for long-term detection of the presence of isotonitazene. CONCLUSION: The study employed advanced high-resolution accurate mass LC-MS techniques to detect and identify the in vitro metabolites of isotonitazene in camels. Isotonitazene is a highly active psychoactive substance with significant potential for abuse, particularly in racing contexts. These findings are crucial for developing effective doping control strategies, which will improve regulation and monitoring in camel racing events and promote animal welfare.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In some Arabic countries, nitazenes are used in camel racing as doping agents.
“In some Arabic countries, these compounds are used in camel racing as doping agents [65,66].”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [65]
The Abstract and Introduction discuss nitazenes as a potential doping concern in camel racing, and the study develops a method for doping control. They do not establish that nitazenes are actually used as doping agents in camel racing or locate such use in Arabic countries. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Joint effect of ageing and multilayer structure prevents ordering in the voter model
Artime, O., Fernández-Gracia, J., Ramasco, J. J., & Miguel, M. S. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.48550/arxiv.1703.06073 · Cited by 5,608 · see citing works
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr‐Walker, J., & Lynch, K. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 714 · see citing works
Smith, H. S. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60750-7 · Cited by 666 · see citing works
New psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H. R., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 350 · see citing works
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161 · see citing works
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146 · see citing works
Treatment of overdose in the synthetic opioid era
Skolnick, P. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108019 · Cited by 123 · see citing works
Applications of Metabolomics in Forensic Toxicology and Forensic Medicine
Szeremeta, M., Pietrowska, K., Niemcunowicz‐Janica, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063010 · Cited by 118 · see citing works
Blanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116 · see citing works
Walton, S. E., Krotulski, A. J., & Logan, B. K. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab117 · Cited by 92 · see citing works
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89 · see citing works
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Pergolizzi Jr, J., Raffa, R., LeQuang, J. A. K., Breve, F., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.40736 · Cited by 81 · see citing works
Vincenti, F., Montesano, C., Ottavio, F. D., Gregori, A., Compagnone, D., Sergi, M., & Dorrestein, P. C. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.572952 · Cited by 66 · see citing works
An Update on the Implications of New Psychoactive Substances in Public Health
Simão, A. Y., Antunes, M., Cabral, E., Oliveira, P., Rosendo, L. M., Brinca, A. T., Alves, E., Marques, H., Rosado, T., Passarinha, L. A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084869 · Cited by 53 · see citing works
Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers
Kanamori, T., Okada, Y., Segawa, H., Yamamuro, T., Kuwayama, K., Tsujikawa, K., & Iwata, Y. T. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3415 · Cited by 39 · see citing works
Baerdemaeker, K. D., Dines, A. M., Hudson, S. C., Sund, L. J., Waters, M., Hunter, L. J., Blundell, M. S., Archer, J. R. H., Wood, D. M., & Dargan, P. I. (2022) · QJM · doi:10.1093/qjmed/hcac039 · Cited by 21 · see citing works
Francesco, G. D., Montesano, C., Vincenti, F., Bilel, S., Corli, G., Petrella, G., Cicero, D. O., Gregori, A., Marti, M., & Sergi, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-60045-2 · Cited by 19 · see citing works
Zhao, K., Dai, Y., Wang, Y., Liu, J., Gu, J., Bai, H., Wurita, A., & Hasegawa, K. (2023) · Legal Medicine · doi:10.1016/j.legalmed.2023.102295 · Cited by 11 · see citing works
Gray, A., Douglas, S., Tiller, M., & Bleakley, M. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae035 · Cited by 7 · see citing works
Nalakath, J., Rasik, R. P., Kadry, A. M., Palathinkal, A. B., Komathu, P. O., Nelliyott, I. W., Hebel, C., Selvapalam, N., & Nagarajan, E. R. (2023) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9626 · Cited by 5 · see citing works
Self-citationNalakath, J., Rasik, R. P., Kadry, A. M., Palathinkal, A. B., Nelliyott, I. W., Komathu, P. O., Hebel, C., Selvapalam, N., & Nagarajan, E. R. (2024) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9846 · Cited by 5 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- European Monitoring Centre for Drugs and Drug Addiction, Syn- thetic Opioids in Europe (Publications Office of the European Union, 2020, accessed on 10.07.2024), https:// doi. org/ 10. 2810/ 420678. · DOI
- European Monitoring Centre for Drugs and Drug Addiction, Drug- Related Deaths and Mortality in Europe (Publications Office of the Eu- ropean Union, 2021), https:// doi. org/ 10. 2810/ 777564. · DOI
- J. P. Smith, O. B. Sutcliffe, and C. E. Banks, "An Overview of Recent Developments in the Analytical Detection of New Psychoactive Sub- stances (NPSs)," Analyst 140, no. 15 (2015): 4932-4948, https:// doi. org/ 10. 1039/ c5an0 0797. · DOI
Cited by
Sorted by citations
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 35 · see citing works
Nitazenes: The Emergence of a Potent Synthetic Opioid Threat
Pereira, J. R. P., Quintas, A., & Neng, N. R. (2025) · Molecules · doi:10.3390/molecules30193890 · Cited by 21 · see citing works
“In some Arabic countries, these compounds are used in camel racing as doping agents [65,66].”
Nalakath, J., Palathinkal, A. B., Naduvilakkandy, R., Vazhat, R. A., & Komathu, P. O. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10111 · Cited by 3 · see citing works
Self-citation
- Authors
- Nalakath, J., Thacholil, R. P., Kadry, A., P, S., & Praseen, O. K.
- Affiliations
- Central Veterinary Research Laboratory (AE)
- Camel Forensic Laboratory Central Veterinary Research Laboratory Dubai UAE
- Corresponding author
- Nalakath, Jahfar
- Venue
- Rapid Communications in Mass Spectrometry
- Publisher
- Wiley
- Published
- 2025-01-05
- Volume
- 39
- Issue
- 7
- Pages
- e9982-e9982
- ISSN
- 0951-4198 (ISSN-L)
- 1097-0231
- OpenAlex
- W4406113761
- Cited by
- 6
- References
- 21
- Citations by year
- 2026: 1 · 2025: 5
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Rapid Communications in Mass Spectrometry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- isotonitazene, new psychoactive substances, metabolite identification, in vitro metabolism, camels, camel racing, doping control, animal welfare, benzimidazole, dealkylation, hydroxylation, phase I metabolism
- MeSH terms
- Animals, Camelus, Chromatography, Liquid, Doping in Sports, Liver, Psychotropic Drugs, Mass Spectrometry, Substance Abuse Detection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
